<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR152" class="ref">
 <label class="label">152.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Kanai</surname>
    <given-names class="given-names">M</given-names>
   </name>
   <name class="name">
    <surname class="surname">Imaizumi</surname>
    <given-names class="given-names">A</given-names>
   </name>
   <name class="name">
    <surname class="surname">Otsuka</surname>
    <given-names class="given-names">Y</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sasaki</surname>
    <given-names class="given-names">H</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hashiguchi</surname>
    <given-names class="given-names">M</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tsujiko</surname>
    <given-names class="given-names">K</given-names>
   </name>
   <name class="name">
    <surname class="surname">Matsumoto</surname>
    <given-names class="given-names">S</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ishiguro</surname>
    <given-names class="given-names">H</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chiba</surname>
    <given-names class="given-names">T</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers</article-title>
  <source class="source">Cancer Chemother Pharmacol</source>
  <year class="year">2012</year>
  <volume class="volume">691</volume>
  <fpage class="fpage">65</fpage>
  <lpage class="lpage">70</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s00280-011-1673-1</pub-id>
 </element-citation>
</ref>
